Read + Share
Amedeo Smart
Independent Medical Education
Yi X, Lou L, Wang J, Xiong J, et al. Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway. Cancer Chemother Pharmacol 2021 Feb 5. pii: 10.1007/s00280-021-04238.PMID: 33544209
Email
LinkedIn
Facebook
Twitter
Privacy Policy